Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors

Biochemical Pharmacology

Volumn 53, Issue 9, 1997, Pages 1357-1368

  McBain, John A ^a,b   Eastman, Alan ^b   Nobel, C Stefan ^c   Mueller, Gerald C ^d  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apoptosis; Butyric acid; Colon cancer; Histone acetylation; Isovaleric acid; Phorbol ester; Trichostatin

Indexed keywords

2 METHYLBUTYRIC ACID; ACETIC ACID; BUTYRIC ACID; ENZYME INHIBITOR; HEXANOIC ACID; ISOVALERIC ACID; PIVALIC ACID; VALERIC ACID;

ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; APOPTOSIS; BUTYRIC ACID; BUTYRIC ACIDS; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FATTY ACIDS, VOLATILE; HISTONE DEACETYLASES; HISTONES; HUMANS; HYDROXAMIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0030741385     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00904-5     Document Type: Article

References (53)

1. Kruh J, Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 42: 65-82, 1982.
2. Harig JM, Soergel KH, Komorowski RA and Wood CM, Treatment of diversion colitis with short-chain fatty acid irrigation. N Engl J Med 20: 23-28, 1989.
3. Scheppach W, Sommer H, Kirchner T, Paganelli G-M, Bartram P, Christi S, Richter S, Dusel F and Kasper H, Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103: 51-56, 1992.
4. Koruda MJ, Rolandelli RH, Bliss DZ, Hastings J, Rombeau JL and Settle RG, Parenteral nutrition supplemented with short-chain fatty acids: Effect on the small bowel mucosa in normal rats. Am J Clin Nutr 51: 685-689, 1990.
5. Scheppach W, Bartram P, Richter A, Liepold H, Dusel G, Hofstetter G, Ruthlein J and Kasper H, Effect of short-chain fatty acids on the human colonic mucosa in vitro. J Parenter Enteral Nutr 16: 43-48, 1992.
6. Roediger WEW, Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83: 424-429, 1982.
7. Barnard JA and Warwick G, Butyrate rapidly induces growth inhibition and differentiation in HT29 cells. Cell Growth Differ 4: 495-501, 1993.
8. c-lck associated with butyrate-induced differentiation of human colon carcinoma cells. Oncogens Res 5: 13-23, 1989.
9. Chung YS, Song IS, Erickson RH, Sleisenger MH and Kim YS, Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res 45: 2976-2982, 1985.
10. McBain JA, Eastman A, Simmons DL, Pettit GR and Mueller GC, Phorbol ester augments butyrate-induced apoptosis of colon cancer cells. Int J Cancer 67: 715-723, 1996.
11. Bell PA and Jones CN, Cytotoxic effects of butyrate and other 'differentiation inducers' on immature lymphoid cells. Biochem Biophys Res Commun 104: 1202-1208, 1982.
12. Ho SB, Yan P-S, Dahiya R, Neuschwander-Teri BA, Basbaum C and Kim YS, Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance. J Cell Physiol 160: 213-226, 1994.
13. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D and Paraskeva C, Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55: 498-505, 1993.
14. Hague A, Elder DJ, Hicks DJ and Paraskeva C, Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate, and acetate, and by the bile salt deoxycholate. Int J Cancer 60: 400-406, 1995.
15. Langdon SP, Hawkes MM, Hay FG, Lawrie SS, Schol DJ, Hilgers J, Leonard RCF and Smyth JF, Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res 48: 6161-6165, 1988.
16. Friend C, Zajak-Kaye M, Holland JG and Pogo BG-T, Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation. Cancer Res 47: 378-382, 1987.
17. Graham KA and Buick RN, Sodium butyrate induces differentiation in breast cancer cell lines expressing the estrogen receptor. J Cell Physiol 136: 63-71, 1988.
18. Halgunset J, Lamvik T and Espevik T, Butyrate effects on growth, morphology, and fibronectin production in PC-3 prostatic carcinoma cells. Prostate 12: 65-77, 1988.
19. Cummings JH, Pomare EW, Branch WJ, Naylor CPE and MacFarlane GT, Short chain fatty acids in human large intestine, portal, hepatic, and venous blood. Gut 28: 1221-1227, 1987.
20. Boffa LC, Lupto JR, Mariani MR, Ceppi M, Newmark HL, Scamati A and Lipkin M, Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 52: 5906-5912, 1992.
21. - channels in the stimulation of chloride absorption by short-chain farry acids in the rat colon. Acta Physiol Scand 151: 385-394, 1994.
22. +-independent short-chain fatty acid transporter contributes to intracellular pH regulation in murine colonocytes. J Gen Physiol 105: 589-615, 1995.
23. Brunkhorst BA, Kraus E, Coppi M, Budnick M and Niederman R, Propionate induces polymorphonuclear leukocyte activation and inhibits formylmethionyl-leucyl-phenylalanine-stimulated activation. Infect Immun 60: 2957-2968, 1992.
24. Cousens LS, Gallwitz D and Alberts BM, Different accessibilities in chromatin to histone acetylase. J Biol Chem 254: 1716-1723, 1979.
25. Csordas A, On the biological role of histone acetylation. Biochem J 265: 23-38, 1990.
26. Davie JR and Hendzel MJ, Multiple functions of dynamic histone acetylation. J Cell Biochem 55: 98-105, 1994.
27. Anderson KE, Whitlon DS and Mueller GC, Role of fatty acid structure in the reversible activation of phosphatidylcholine synthesis in lymphocytes. Biochim Biophys Acta 835: 360-368, 1985.
28. Heerdt BG and Augenlicht LH, Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells. J Biol Chem 266: 19120-19126, 1991.
29. Yoshida M, Kijima M, Akita M and Beppu T, Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265: 17174-17179, 1990.
30. McBain JA, Weese JL, Meisner LF, Wolfberg WH and Willson JKV, Establishment and characterization of human colorectal cancer cell lines. Cancer Res 44: 5813-5821, 1984.
31. De Luca C, The use of trypsin for the determination of cellular viability. Exp Cell Res 40: 186-188, 1965.
32. Loidl P and Gröbner P, Biosynthesis and posttranslational acetylation of histones during spherulation of Physarum polycephalum. Nucleic Acids Res 14: 3745-3762, 1986.
33. Zweidler A, Resolution of histones by polyacrylamide gel electrophoresis in the presence of nonionic detergents. Methods Cell Biol 17: 223-234, 1978.
34. Barry MA, Behnke CA and Eastman A, Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins, and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
35. Almouzni G, Khochbin S, Dimitrov S and Wolffe AP, Histone acetylation influences both gene expression and development of Xenopus laevis. Devl Biol 165: 654-669, 1994.
36. Chalkley R and Shires A, The isolation of HTC variant cells which can replicate in butyrate. Change in histone acetylation and tyrosine aminotransferase induction. J Biol Chem 260: 7698-7704, 1985.
37. Ohlsson-Wilhelm BM, Farley BA, Kosciolek B, La Bella S and Rowley PT, K562 human erythroleukemia cell variants resistant to growth inhibition by butyrate have deficient histone acetylation. Am J Hum Genet 36: 1225-1238, 1984.
38. Wyllie AH, Kerr JFR and Currie AR, Cell death: The significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
39. + antiport. J Biol Chem 270: 3203-3211, 1995.
40. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and Kroemer G, Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182: 367-377, 1995.
41. Glauber JG, Wandersee NJ, Little JA and Ginder GD, 5′-Flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol Cell Biol 11: 4690-4697, 1991.
42. 2+ requiring mechansim. J Biol Chem 265: 17323-17333, 1990.
43. Birren BW, Taplitz SJ and Herschman HR, Butyrate-induced changes in nuclease sensitivity of chromatin cannot be correlated with transcriptional activation Mol Cell Biol 71: 3863-3870, 1987.
44. Hojo ETS, Balajee AS and Natarajan AT, Modulatory effect of sodium butyrate on Alu I-induced chromosomal aberrations in CHO cells. Mutat Res 309: 165-173, 1994.
45. Perry CA and Annunziato AT, Histone acetylation reduces H1-mediated nucleosome interactions during chromatin assembly. Exp Cell Res 196: 337-345, 1991.
46. Schröter H, Gömez-Lira MM, Plank K-H and Bode J, The extent of histone acetylation induced by butyrate and the turnover of acetyl groups depend on the nature of the cell line. Eur J Biochem 120: 21-28, 1981.
47. Sweetman L, Branched chain organic acidurias. In: Metabolic Basis of Inherited Disease (Ed. Stanbury JB), pp. 791-819. McGraw Hill, New York, 1989.
48. Kelleher JF, Yudkoff M, Hutchinson R, August CS and Cohn RM, The pancytopenia of isovaleric acidemia. Pediatrics 65: 1023-1027, 1980.
49. Tanaka K, Jamaican vomiting sickness. In: Handbook of Clinical Neurology, (Eds. Vinken PJ and Bruyn GW), Vol. 37, pp. 791-819. Elsevier, Amsterdam, 1979.
50. Ikeda Y and Tanaka K, Selective inactivation of various acyl-CoA dehydrogenases by (methylenecyclopropyl) acetyl-CoA. Biochim Biophys Acta 1038: 216-221, 1990.
51. Miller AA, Kurschel E, Osieka R and Schmidt CG, Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Oncol 23: 1283-1287, 1987.
52. Sher GD, Ginder GD, Little J, Yang S, Dover GJ and Olivieri NF, Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinopathies. N Engl J Med 332: 1606-1610, 1995.
53. Yuan Z, Eiseman J, Plaisance K, Sentz D, Bigora S, Fosler M, Young D and Egorin M, Plasma pharmacokinetics of butyrate after the administration of tributyrin and sodium butyrate to mice and rats. Proc Am Assoc Cancer Res 35: 429, 1994.